IT1181627B - Composizioni farmaceutiche stabili di agenti di blocco dei recettori beta-adrenergici per la profilassi ed il trattamento di disordini cardiaci - Google Patents
Composizioni farmaceutiche stabili di agenti di blocco dei recettori beta-adrenergici per la profilassi ed il trattamento di disordini cardiaciInfo
- Publication number
- IT1181627B IT1181627B IT47928/85A IT4792885A IT1181627B IT 1181627 B IT1181627 B IT 1181627B IT 47928/85 A IT47928/85 A IT 47928/85A IT 4792885 A IT4792885 A IT 4792885A IT 1181627 B IT1181627 B IT 1181627B
- Authority
- IT
- Italy
- Prior art keywords
- prophylaxis
- beta
- treatment
- pharmaceutical compositions
- adrenergic receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/598,131 US4579867A (en) | 1984-04-09 | 1984-04-09 | Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents |
Publications (3)
Publication Number | Publication Date |
---|---|
IT8547928A0 IT8547928A0 (it) | 1985-04-05 |
IT8547928A1 IT8547928A1 (it) | 1986-10-05 |
IT1181627B true IT1181627B (it) | 1987-09-30 |
Family
ID=24394367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT47928/85A IT1181627B (it) | 1984-04-09 | 1985-04-05 | Composizioni farmaceutiche stabili di agenti di blocco dei recettori beta-adrenergici per la profilassi ed il trattamento di disordini cardiaci |
Country Status (9)
Country | Link |
---|---|
US (1) | US4579867A (it) |
EP (1) | EP0179807B1 (it) |
JP (1) | JPS61501774A (it) |
AU (1) | AU575152B2 (it) |
CA (1) | CA1242146A (it) |
DE (1) | DE3585134D1 (it) |
IT (1) | IT1181627B (it) |
WO (1) | WO1985004581A1 (it) |
ZA (1) | ZA852321B (it) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4798892A (en) * | 1981-11-12 | 1989-01-17 | E. I. Du Pont De Nemours And Company | 2-hydroxypropylamine heteroaryl ester derivatives |
US4966914A (en) * | 1988-12-15 | 1990-10-30 | E. I. Du Pont De Nemours And Company | Oculoselective beta-blockers as antiglaucoma agents |
US4897417A (en) * | 1988-12-15 | 1990-01-30 | E. I. Du Pont De Nemours & Co. | Prodrugs of 3,4-hydroxy benzoyloxypropanolamines |
HU209251B (en) * | 1992-03-13 | 1994-04-28 | Synepos Ag | Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons |
WO1999061055A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
JP4202250B2 (ja) | 2001-07-25 | 2008-12-24 | バイオマリン ファーマシューティカル インコーポレイテッド | 血液脳関門輸送を調節するための組成物および方法 |
DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
US8795627B2 (en) | 2007-03-21 | 2014-08-05 | Raptor Pharmaceuticals Inc. | Treatment of liver disorders by administration of RAP conjugates |
CA2969926C (en) | 2009-02-20 | 2018-05-15 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
IL295075A (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
CN113533707B (zh) * | 2021-07-13 | 2024-05-28 | 重庆德方信息技术有限公司 | 尿液检测卡自动装配装置 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1476934A (en) * | 1922-02-13 | 1923-12-11 | Abbott Lab | Anaesthetic compound |
NL301580A (it) * | 1962-12-11 | |||
US4405642A (en) * | 1980-11-28 | 1983-09-20 | American Hospital Supply Corporation | Method for treatment or prophylaxis of cardiac disorders |
US4387103A (en) * | 1980-11-28 | 1983-06-07 | American Hospital Supply Corporation | Method for treatment or prophylaxis of cardiac disorders |
US4402974A (en) * | 1981-06-23 | 1983-09-06 | American Hospital Supply Corporation | Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents |
JPS5822464A (ja) * | 1981-07-31 | 1983-02-09 | Fuji Electric Co Ltd | マルチプロセツサの制御方式 |
JPS5822465A (ja) * | 1981-07-31 | 1983-02-09 | Hitachi Ltd | 磁気デイスク装置システム |
-
1984
- 1984-04-09 US US06/598,131 patent/US4579867A/en not_active Expired - Fee Related
-
1985
- 1985-03-25 WO PCT/US1985/000491 patent/WO1985004581A1/en active IP Right Grant
- 1985-03-25 AU AU41502/85A patent/AU575152B2/en not_active Ceased
- 1985-03-25 JP JP60501517A patent/JPS61501774A/ja active Pending
- 1985-03-25 EP EP85901816A patent/EP0179807B1/en not_active Expired - Lifetime
- 1985-03-25 DE DE8585901816T patent/DE3585134D1/de not_active Expired - Lifetime
- 1985-03-27 ZA ZA852321A patent/ZA852321B/xx unknown
- 1985-03-29 CA CA000477921A patent/CA1242146A/en not_active Expired
- 1985-04-05 IT IT47928/85A patent/IT1181627B/it active
Also Published As
Publication number | Publication date |
---|---|
CA1242146A (en) | 1988-09-20 |
DE3585134D1 (de) | 1992-02-20 |
IT8547928A1 (it) | 1986-10-05 |
EP0179807B1 (en) | 1992-01-08 |
ZA852321B (en) | 1985-11-27 |
IT8547928A0 (it) | 1985-04-05 |
EP0179807A4 (en) | 1987-10-27 |
JPS61501774A (ja) | 1986-08-21 |
WO1985004581A1 (en) | 1985-10-24 |
AU4150285A (en) | 1985-11-01 |
EP0179807A1 (en) | 1986-05-07 |
AU575152B2 (en) | 1988-07-21 |
US4579867A (en) | 1986-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1177553B (it) | Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione | |
IT8647603A0 (it) | Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita' | |
IT8449164A0 (it) | Ti sucralfat e procedimento per la composizioni farmaceutiche contenenloro stabilizzazione | |
NO851695L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater | |
IT1184271B (it) | Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci | |
IT1181627B (it) | Composizioni farmaceutiche stabili di agenti di blocco dei recettori beta-adrenergici per la profilassi ed il trattamento di disordini cardiaci | |
IT1187717B (it) | Procedimento per la preparazione di derivati 3-sostituiti dell'1-amino-2-idrossi-propano | |
IT9067434A0 (it) | Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento | |
NO854369L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater | |
IT1147841B (it) | Preparati farmaceutici per la profilassi ed il trattamento di insufficienza di rendimento cerebrale | |
IT8348294A0 (it) | Composti e composizioni per il trattamento delle affezioni cardiocircolatorie e procedimento di preparazione | |
IT8448983A1 (it) | Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina | |
DE3460620D1 (en) | Pharmaceutical or veterinary composition for the treatment of ischemic cardiac disorders | |
IT1214843B (it) | Composizione farmaceutica sinergistica per il trattamento di disturbi epatici contenente 4(5)-amminoimidazolo-5(4)carbossamide ortofosfato e vitamine | |
GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
IT8423896A0 (it) | Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche. | |
IT8420682A1 (it) | "Procedimento per il trattamento di articoli di maglieria" | |
NO170012C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider | |
NO170569C (no) | Fremgangsmaate for fremstilling av preparat for oral dosering av etoposid | |
IT8103423A0 (it) | Derivati di alcandioli conattivita' ipolipidemizzante, metodi per la loro preparazione e composizioni farmaceutiche che licontengono | |
IT8467183A1 (it) | Composizione farmaceutica per la profilassi ed il trattamento dell'arteriosclerosi. | |
IT9021002A0 (it) | Agente per la prevenzione ed il trattamento dell'opacita' del cristallino | |
ITMI911445A0 (it) | Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva | |
IT1200460B (it) | Composizioni di farmaci dotae di attivita' antimicrobica e procedimento per la loro preparazione | |
IT1184671B (it) | Composizione erbicida e procedimento per la preparazione del suo ingrediente attivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19940429 |